» Articles » PMID: 35908574

Necroptosis Pathways in Tumorigenesis

Overview
Specialty Oncology
Date 2022 Jul 31
PMID 35908574
Authors
Affiliations
Soon will be listed here.
Abstract

Necroptosis is a caspase-independent form of programmed cell death executed by the receptor interacting protein kinase 1 (RIPK1)-RIPK3-mixed lineage kinase domain-like protein (MLKL) signaling cascade, deregulation of which can cause various human diseases including cancer. Escape from programmed cell death is a hallmark of cancer, leading to uncontrolled growth and drug resistance. Therefore, it is crucial to further understand whether necroptosis plays a key role in therapeutic resistance. In this review, we summarize the recent findings of the link between necroptosis and cancer, and discuss that targeting necroptosis is a new strategy to overcome apoptosis resistance in tumor therapy.

Citing Articles

New insights into pulmonary arterial hypertension: interaction between PANoptosis and perivascular inflammatory responses.

Su X, Sun Y, Dai A Apoptosis. 2025; .

PMID: 39979525 DOI: 10.1007/s10495-025-02086-0.


CASC8 activates the pentose phosphate pathway to inhibit disulfidptosis in pancreatic ductal adenocarcinoma though the c-Myc-GLUT1 axis.

Yao H, Ge J, Chen J, Tang X, Li C, Hu X J Exp Clin Cancer Res. 2025; 44(1):26.

PMID: 39865281 PMC: 11771065. DOI: 10.1186/s13046-025-03295-w.


Necroptosis-Related Gene Signature Predicts Prognosis in Patients with Advanced Ovarian Cancer.

Zheng M, Kessler M, Jeschke U, Reichenbach J, Czogalla B, Keckstein S Cancers (Basel). 2025; 17(2).

PMID: 39858052 PMC: 11763378. DOI: 10.3390/cancers17020271.


Cuproptosis: molecular mechanisms, cancer prognosis, and therapeutic applications.

Cong Y, Li N, Zhang Z, Shang Y, Zhao H J Transl Med. 2025; 23(1):104.

PMID: 39844182 PMC: 11752808. DOI: 10.1186/s12967-025-06121-1.


Biological and pharmacological roles of pyroptosis in pulmonary inflammation and fibrosis: recent advances and future directions.

Liu Y, Wang D, Liu X, Yuan H, Liu D, Hu Y Cell Commun Signal. 2024; 22(1):586.

PMID: 39639365 PMC: 11619304. DOI: 10.1186/s12964-024-01966-3.


References
1.
Barati M, Javidi M, Darvishi B, Shariatpanahi S, Mesbah Moosavi Z, Ghadirian R . Necroptosis triggered by ROS accumulation and Ca overload, partly explains the inflammatory responses and anti-cancer effects associated with 1Hz, 100 mT ELF-MF in vivo. Free Radic Biol Med. 2021; 169:84-98. DOI: 10.1016/j.freeradbiomed.2021.04.002. View

2.
Forbes S, Bhamra G, Bamford S, Dawson E, Kok C, Clements J . The Catalogue of Somatic Mutations in Cancer (COSMIC). Curr Protoc Hum Genet. 2008; Chapter 10:Unit 10.11. PMC: 2705836. DOI: 10.1002/0471142905.hg1011s57. View

3.
He L, Peng K, Liu Y, Xiong J, Zhu F . Low expression of mixed lineage kinase domain-like protein is associated with poor prognosis in ovarian cancer patients. Onco Targets Ther. 2013; 6:1539-43. PMC: 3817086. DOI: 10.2147/OTT.S52805. View

4.
Wang H, Sun L, Su L, Rizo J, Liu L, Wang L . Mixed lineage kinase domain-like protein MLKL causes necrotic membrane disruption upon phosphorylation by RIP3. Mol Cell. 2014; 54(1):133-146. DOI: 10.1016/j.molcel.2014.03.003. View

5.
Jing L, Song F, Liu Z, Li J, Wu B, Fu Z . MLKL-PITPα signaling-mediated necroptosis contributes to cisplatin-triggered cell death in lung cancer A549 cells. Cancer Lett. 2017; 414:136-146. DOI: 10.1016/j.canlet.2017.10.047. View